MedTrace Logo

Identification of Biomarkers for Prediction of Response or Resistance Against Target Therapy in Gastric Cancer

NCT02305043 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 549

Last updated 2018-07-11

No results posted yet for this study

Summary

The aim of this study is to identify biomarkers predicting response or resistance factors of a targeted therapy with trastuzumab in advanced gastric cancer.

Conditions

  • Esophageal Neoplasms
  • Stomach Neoplasms

Interventions

OTHER

non-interventional

non-interventional

Sponsors & Collaborators

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV

  • University of Leipzig

    lead OTHER

Principal Investigators

  • Florian Lordick, Prof. · University Cancer Center Leipzig

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02305043 on ClinicalTrials.gov